Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
about
A single amino acid determines preference between phospholipids and reveals length restriction for activation of the S1P4 receptorLysophosphatidic acid inhibits cholera toxin-induced secretory diarrhea through CFTR-dependent protein interactionsPhylogenetic analysis of 277 human G-protein-coupled receptors as a tool for the prediction of orphan receptor ligands.NHERF2 specifically interacts with LPA2 receptor and defines the specificity and efficiency of receptor-mediated phospholipase C-beta3 activationIdentification and characterization of a novel lysophosphatidic acid receptor, p2y5/LPA6A novel acylglycerol kinase that produces lysophosphatidic acid modulates cross talk with EGFR in prostate cancer cellsIdentification of a molecular target of psychosine and its role in globoid cell formation.Lysophosphatidic acid (LPA) signaling in human and ruminant reproductive tractLipid phosphate phosphatase (LPP3) and vascular developmentPharmacological tools for lysophospholipid GPCRs: development of agonists and antagonists for LPA and S1P receptors.International Union of Basic and Clinical Pharmacology. LXXVIII. Lysophospholipid receptor nomenclature.Role of LPA4/p2y9/GPR23 in negative regulation of cell motilityBiological roles of lysophospholipid receptors revealed by genetic null mice: an update.Lysophosphatidic acid (LPA) signaling in vertebrate reproduction.LPA induces IL-6 secretion from aortic smooth muscle cells via an LPA1-regulated, PKC-dependent, and p38alpha-mediated pathwayLPA receptor signaling: pharmacology, physiology, and pathophysiology.Lysophospholipid receptor nomenclature review: IUPHAR Review 8.Characterization of lpa(2) (Edg4) and lpa(1)/lpa(2) (Edg2/Edg4) lysophosphatidic acid receptor knockout mice: signaling deficits without obvious phenotypic abnormality attributable to lpa(2).Aiming drug discovery at lysophosphatidic acid targets.Distribution of endogenous farnesyl pyrophosphate and four species of lysophosphatidic acid in rodent brain.LPA(1) -induced migration requires nonmuscle myosin II light chain phosphorylation in breast cancer cellsInsights into the pharmacological relevance of lysophospholipid receptors.LPA receptor 1 mediates LPA-induced ovarian cancer metastasis: an in vitro and in vivo study.Lysophosphatidic acid induces prostate cancer PC3 cell migration via activation of LPA(1), p42 and p38alpha.Migration of gastric cancer cells in response to lysophosphatidic acid is mediated by LPA receptor 2The role of LPA and YAP signaling in long-term migration of human ovarian cancer cells.Lysophosphatidic acid signaling in airway epithelium: role in airway inflammation and remodeling.Lysophosphatidic acid enhances pulmonary epithelial barrier integrity and protects endotoxin-induced epithelial barrier disruption and lung injury.Role of lysophosphatidic acid receptor LPA2 in the development of allergic airway inflammation in a murine model of asthma.Serotonergic neuron regulation informed by in vivo single-cell transcriptomics.The effect of lysophosphatidic acid during in vitro maturation of bovine oocytes: embryonic development and mRNA abundances of genes involved in apoptosis and oocyte competence.Convergent regulation of neuronal differentiation and Erk and Akt kinases in human neural progenitor cells by lysophosphatidic acid, sphingosine 1-phosphate, and LIF: specific roles for the LPA1 receptorLysophosphatidic acid effects on atherosclerosis and thrombosis.Subtype-specific residues involved in ligand activation of the endothelial differentiation gene family lysophosphatidic acid receptorsLysophospholipid signaling: beyond the EDGs.Expression of factors involved in apoptosis and cell survival is correlated with enzymes synthesizing lysophosphatidic acid and its receptors in granulosa cells originating from different types of bovine ovarian follicles.Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter.Increased expression of CYR61, an extracellular matrix signaling protein, in human benign prostatic hyperplasia and its regulation by lysophosphatidic acidAutotaxin-Lysophosphatidic Acid: From Inflammation to Cancer Development.LPA-binding receptors bind LPA
P2860
Q21093656-92EA69EF-5EE1-48AA-A34F-AA7D5C0237D7Q24337629-673A9C3E-5130-459A-B7A5-AEE27E5EAC3BQ24536334-1AFBD499-4037-48FB-B656-E8A1C8195AFEQ24563311-910D7B11-3A78-43BD-B21E-9BD91166C6A7Q24658261-0B736CE6-C4F8-4796-9F5C-0FA49F179A61Q24678857-7B00BB37-4564-47AC-9E19-71B508FEE25BQ24680348-53685FCE-D602-4385-B7D4-0BE2B424296BQ26829938-90EF88DF-5E2A-4A8D-8786-DE419AE6C3B0Q27002640-E2767FB8-97EB-43FA-AD25-37C8A7587056Q30410634-D7CBF618-F51B-4D21-B599-140E7A86B1C5Q30429523-B9056BB6-D738-4DF4-9B15-21A0F06E0E62Q30440331-AB085F1D-82FE-4CCC-9618-370197852F1EQ30487082-8E6F2055-1D88-4737-AAC2-3A039C38C437Q33636488-06B3C27E-8854-414E-B431-BB69CD2FEF15Q33727578-C7DC1C9E-2289-418D-988D-C1C9AE0A8F47Q33825153-DC292F68-075D-4018-A86D-B49A1703C297Q34025135-E3832238-40A8-46E4-A0B0-6FC036B1EEC4Q34285790-2879DAE1-4180-4B3B-B8A5-6B60C8FA15C5Q34339759-81C6DF62-AF57-4D7E-AA1F-2088E656F41BQ34378141-AFB67559-0CFC-4B4E-AC87-5C30F0EC3CE0Q35046383-255054B1-294F-4CB0-96C9-6D93AB4037A2Q35853199-87543A9D-D651-4C4B-B9C1-B23425017005Q36181402-11CF7AE0-3D09-4F72-A184-979B0DAA11A4Q36246902-EE672562-30D4-4A93-9B5F-1C1DBDDFAC97Q36621591-CB4C88E5-C57D-46D3-8DFD-D2D0CEA4D69AQ36847992-C0EBB84F-27AA-49C2-AF20-9A179E9BD8CFQ37139302-CBF81E3A-23D2-4E02-A2C6-9659FA844D9BQ37433301-D2F35F92-752C-47C4-9BB4-DBCAD9D886EFQ37458620-48B288D7-D472-45D1-B49E-1E3BE4F74EC1Q37503693-67AF0750-6D22-4E18-95A4-E8049C74DF2CQ37651120-AD61D4D9-BDCD-4AD0-AD91-C9C075914B32Q38937797-19EEF24A-E334-4E52-859D-E80A3E797382Q39608397-27E35DE4-F514-4B4E-8235-747FC98ACA9FQ40006406-FCBE3370-29E8-472A-A88E-C6B445350587Q40068942-0CAA2E42-054B-4D4A-A7DC-56E122A4A686Q41625562-64905658-63FF-4973-B46C-186CB75B32CBQ41851148-BB114664-810D-4BF6-972B-917AB899FB67Q42410865-131A2D28-6906-4BD0-B57D-5429C121D0D6Q50074055-C8FC9ACF-277D-4978-BD05-274FFC5C3C9FQ50298356-CE30D4CC-E178-42A9-9AA8-BF6924D06C06
P2860
Molecular cloning and characterization of a lysophosphatidic acid receptor, Edg-7, expressed in prostate
description
2000 nî lūn-bûn
@nan
2000 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2000 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2000年の論文
@ja
2000年論文
@yue
2000年論文
@zh-hant
2000年論文
@zh-hk
2000年論文
@zh-mo
2000年論文
@zh-tw
2000年论文
@wuu
name
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@ast
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@en
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@nl
type
label
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@ast
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@en
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@nl
prefLabel
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@ast
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@en
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@nl
P2093
P3181
P1476
Molecular cloning and characte ...... , Edg-7, expressed in prostate
@en
P2093
B F O'Dowd
D Theodorescu
M A Harding
S R George
P3181
P407
P577
2000-04-01T00:00:00Z